Literature DB >> 16955143

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling.

Karl S Lang1, Panco Georgiev, Mike Recher, Alexander A Navarini, Andreas Bergthaler, Mathias Heikenwalder, Nicola L Harris, Tobias Junt, Bernhard Odermatt, Pierre-Alain Clavien, Hanspeter Pircher, Shizuo Akira, Hans Hengartner, Rolf M Zinkernagel.   

Abstract

The liver is known to be a classical immunoprivileged site with a relatively high resistance against immune responses. Here we demonstrate that highly activated liver-specific effector CD8+ T cells alone were not sufficient to trigger immune destruction of the liver in mice. Only additional innate immune signals orchestrated by TLR3 provoked liver damage. While TLR3 activation did not directly alter liver-specific CD8+ T cell function, it induced IFN-alpha and TNF-alpha release. These cytokines generated expression of the chemokine CXCL9 in the liver, thereby enhancing CD8+ T cell infiltration and liver disease in mice. Thus, nonspecific activation of innate immunity can drastically enhance susceptibility to immune destruction of a solid organ.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16955143      PMCID: PMC1555644          DOI: 10.1172/JCI28349

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease.

Authors:  Karl S Lang; Mike Recher; Tobias Junt; Alexander A Navarini; Nicola L Harris; Stefan Freigang; Bernhard Odermatt; Curdin Conrad; Lars M Ittner; Stefan Bauer; Sanjiv A Luther; Satoshi Uematsu; Shizuo Akira; Hans Hengartner; Rolf M Zinkernagel
Journal:  Nat Med       Date:  2005-01-16       Impact factor: 53.440

2.  A young woman with hepatitis after a sore throat.

Authors:  A Aceti; M S Mura; S Babudieri; S A Bacciu
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

3.  Measles and autoimmune chronic active hepatitis.

Authors:  G Mieli-Vergani; S Sutherland; A P Mowat
Journal:  Lancet       Date:  1989-09-16       Impact factor: 79.321

4.  Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation.

Authors:  Karl S Lang; Mike Recher; Alexander A Navarini; Nicola L Harris; Max Löhning; Tobias Junt; Hans Christian Probst; Hans Hengartner; Rolf M Zinkernagel
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

Review 5.  Treatment of hepatitis C.

Authors:  Andrew I Kim; Sammy Saab
Journal:  Am J Med       Date:  2005-08       Impact factor: 4.965

Review 6.  Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.

Authors:  G L Bumgardner; C G Orosz
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

7.  Break of T cell ignorance to a viral antigen in the liver induces hepatitis.

Authors:  D Voehringer; C Blaser; A B Grawitz; F V Chisari; K Buerki; H Pircher
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

8.  Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C.

Authors:  L García-Buey; C García-Monzón; S Rodriguez; M J Borque; A García-Sánchez; R Iglesias; M DeCastro; F G Mateos; J L Vicario; A Balas
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

9.  CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes.

Authors:  Torsten Sacher; Percy Knolle; Thomas Nichterlein; Bernd Arnold; Günter J Hämmerling; Andreas Limmer
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

10.  Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus.

Authors:  M G von Herrath; M B Oldstone
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

View more
  69 in total

Review 1.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

2.  Autoimmunity stimulated by adoptively transferred dendritic cells is initiated by both alphabeta and gammadelta T cells but does not require MyD88 signaling.

Authors:  David A Martin; Kang Zhang; Justin Kenkel; Grant Hughes; Edward Clark; Anne Davidson; Keith B Elkon
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

3.  Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses.

Authors:  Shenghua Zhou; Annett Halle; Evelyn A Kurt-Jones; Anna M Cerny; Ermelinda Porpiglia; Michael Rogers; Douglas T Golenbock; Robert W Finberg
Journal:  J Neuroimmunol       Date:  2008-02       Impact factor: 3.478

4.  NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice.

Authors:  Rongbin Zhou; Haiming Wei; Rui Sun; Jian Zhang; Zhigang Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

5.  TLR3 signaling does not affect organ-specific immune responses to factor IX in AAV gene therapy.

Authors:  Ou Cao; Roland W Herzog
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

6.  Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection.

Authors:  Li-Rung Huang; Dirk Wohlleber; Florian Reisinger; Craig N Jenne; Ru-Lin Cheng; Zeinab Abdullah; Frank A Schildberg; Margarete Odenthal; Hans-Peter Dienes; Nico van Rooijen; Edgar Schmitt; Natalio Garbi; Michael Croft; Christian Kurts; Paul Kubes; Ulrike Protzer; Mathias Heikenwalder; Percy A Knolle
Journal:  Nat Immunol       Date:  2013-04-14       Impact factor: 25.606

7.  Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency.

Authors:  Michalis Mastri; Zaeem Shah; Terence McLaughlin; Christopher J Greene; Leah Baum; Gen Suzuki; Techung Lee
Journal:  Am J Physiol Cell Physiol       Date:  2012-07-25       Impact factor: 4.249

Review 8.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Type I interferon receptor deficiency prevents murine Sjogren's syndrome.

Authors:  B M Szczerba; P D Rybakowska; P Dey; K M Payerhin; A B Peck; H Bagavant; U S Deshmukh
Journal:  J Dent Res       Date:  2013-03-26       Impact factor: 6.116

10.  Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.

Authors:  Jing Zhou; Jun-O Jin; Juan Du; Qing Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.